Tenax Therapeutics Appoints New Chief Financial Officer

Tenax Therapeutics, Inc. has announced the appointment of Thomas R. Staab, II as its new Chief Financial Officer, effective May 11, 2026. Mr. Staab brings over twenty-five years of financial and executive experience within the healthcare industry to his new role. The current interim CFO will continue in the position until the company files its upcoming Form 10-Q.